Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pujol

Showing results (21-30 of 155) with videos related to

Pageof 16
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2015
Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et alJ-L Pujol, F Morin, G Zalcman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1995
Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSFV Gautier, J L Pujol, F B Michel
Pathologie-Biologie|November 1, 1992
The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trialJ L Pujol, I Tabah, F B Michel
British Journal of Cancer|July 7, 2000
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agentJ L Pujol, L Carestia, J P Daurès
Thorax|June 1, 1990
Long term survival after pulmonary resection for small cell carcinoma of the lungJ L Pujol, P Demoly, F B Michel
Revue Des Maladies Respiratoires|January 1, 1995
[CYFRA 21-1 and bronchial cancer]J L Pujol, J Grenier, F B Michel
Revue Des Maladies Respiratoires|January 1, 1996
[Cellular growth factors in the treatment of bronchogenic cancers]J L Pujol, X Quantin, F B Michel
Revue Des Maladies Respiratoires|September 17, 2013
[Anti-Hu antibodies: a remarkable immulogical phenotype for several paraneoplastic syndromes]J-L Pujol, J-P Di Mercurio, B Carlander
American Journal of Clinical Pathology|October 1, 1989
Heterogeneity of estrogen receptor in primary breast carcinoma evaluated by computed image analysisJ Simony, J L Pujol, J Grenier, et al.
Osteoarthritis and Cartilage|September 18, 2003
The role of reactive oxygen species in homeostasis and degradation of cartilageY E Henrotin, P Bruckner, J-P L Pujol
Pageof 16

Showing results (21-30 of 155) with videos related to

Sort By:
Pageof 16
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 9, 2015
Reply to the letter to the editor 'Flaws in the trial design of IFCT-0802' by Gyawali et alJ-L Pujol, F Morin, G Zalcman, et al.
Lung Cancer (Amsterdam, Netherlands)|October 1, 1995
Interleukin-1 alpha and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSFV Gautier, J L Pujol, F B Michel
Pathologie-Biologie|November 1, 1992
The use of GM-CSF as adjunctive therapy in small cell lung cancer. Presentation of the interim analysis of a large phase II trialJ L Pujol, I Tabah, F B Michel
British Journal of Cancer|July 7, 2000
Is there a case for cisplatin in the treatment of small-cell lung cancer? A meta-analysis of randomized trials of a cisplatin-containing regimen versus a regimen without this alkylating agentJ L Pujol, L Carestia, J P Daurès
Thorax|June 1, 1990
Long term survival after pulmonary resection for small cell carcinoma of the lungJ L Pujol, P Demoly, F B Michel
Revue Des Maladies Respiratoires|January 1, 1995
[CYFRA 21-1 and bronchial cancer]J L Pujol, J Grenier, F B Michel
Revue Des Maladies Respiratoires|January 1, 1996
[Cellular growth factors in the treatment of bronchogenic cancers]J L Pujol, X Quantin, F B Michel
Revue Des Maladies Respiratoires|September 17, 2013
[Anti-Hu antibodies: a remarkable immulogical phenotype for several paraneoplastic syndromes]J-L Pujol, J-P Di Mercurio, B Carlander
American Journal of Clinical Pathology|October 1, 1989
Heterogeneity of estrogen receptor in primary breast carcinoma evaluated by computed image analysisJ Simony, J L Pujol, J Grenier, et al.
Osteoarthritis and Cartilage|September 18, 2003
The role of reactive oxygen species in homeostasis and degradation of cartilageY E Henrotin, P Bruckner, J-P L Pujol
Pageof 16